Cantor Fitzgerald’s Tevogen Inc. Common Stock TVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,074
Closed -$222K 348
2024
Q3
$222K Sell
12,074
-926
-7% -$27.1K 0.01% 135
2024
Q2
$470K Hold
13,000
0.09% 114
2024
Q1
$2.77M Buy
+13,000
New +$4.71M 0.65% 28
2023
Q4
Sell
-3,000
Closed -$1.5M 589
2023
Q3
$1.5M Hold
3,000
0.04% 242
2023
Q2
$1.5M Hold
3,000
0.03% 279
2023
Q1
$1.5M Buy
+3,000
New +$1.59M 0.03% 330
2022
Q3
Sell
-10,000
Closed -$5M 860
2022
Q2
$5M Hold
10,000
0.1% 240
2022
Q1
$5M Buy
+10,000
New +$4.97M 0.38% 74

Other funds holding TVGN

Cantor Fitzgerald's TVGN Position: Q4 2024 in Review

Cantor Fitzgerald sold out of Tevogen Inc. Common Stock (TVGN) in Q4 2024, closing a stake of 12,074 shares — an estimated $222K sold.

Cantor Fitzgerald first reported a position in TVGN in Q1 2022 and held it in 8 quarters. The position peaked at $5M in Q2 2022. 44 funds tracked by Wall St. Rank hold TVGN as of Q4 2024.

  • Cantor Fitzgerald reported no remaining Tevogen Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Cantor Fitzgerald sold 12,074 Tevogen Inc. Common Stock shares in Q4 2024, an estimated $222K.
  • Cantor Fitzgerald first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Cantor Fitzgerald's Tevogen Inc. Common Stock position peaked at $5M in Q2 2022.
  • 44 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q4 2024.

Based on Cantor Fitzgerald's 13F filing for Q4 2024, filed 14 Feb 2025.